secwatch / observer
8-K filed March 5, 2024, 6:59 PM ET ticker SCLX CIK 0001820190
other material confidence high sentiment neutral materiality 0.65

Scilex closes $10M bought deal of 5.88M shares + warrants; discloses ~$3.9M cash

Scilex Holding Co

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

Scilex Holding Co reported preliminary financial results for the quarter and the year ended December 31, 2023.

Period
the quarter and the year ended December 31, 2023
Result
preliminary results
Exact text from the filing
The Company disclosed in the Prospectus Supplement that as of December 31, 2023, it had approximately $3,921,000 in cash and cash equivalents. Because the Company's financial statements for the quarter and the year ended December 31, 2023 have not yet been finalized or audited, these preliminary statements regarding the Company's cash and cash equivalents are subject to change
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scilex Holding Co entered into Underwriting Agreement with Rodman & Renshaw LLC and StockBlock Securities LLC (effective 2024-02-29).

Action
entry
Agreement
underwriting
Counterparty
Rodman & Renshaw LLC and StockBlock Securities LLC
Effective
2024-02-29
Exact text from the filing
On February 29, 2024, Scilex Holding Company (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Rodman & Renshaw LLC and StockBlock Securities LLC, as the representatives (the “Representatives”) of the underwriters named in Schedule A thereto (the “Underwriters”).
View on SEC.gov

321 earnings releases filed in the last 30 days. Browse all earnings releases →

Scilex Holding Co filing history →

Source: SEC EDGAR
accession 0001193125-24-059255
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.